Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde, Lars Køber, Jens-Erik Beck Jensen: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Victor W. Henderson, Rogerio A. Lobo: Hormone therapy and the risk of stroke: perspectives ten years after the Women’s Health Initiative trials. Climacteric : the journal of the International Menopause Society, 2012-6, 15. vsk, nro 3, s. 229–234. PubMed:22612608doi:10.3109/13697137.2012.656254ISSN 1369-7137Artikkelin verkkoversio.
Laura M. Chambers, Alyssa Herrmann, Chad M. Michener, Cecile A. Ferrando, Stephanie Ricci: Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 2020-04, 30. vsk, nro 4, s. 515–524. PubMed:32075898doi:10.1136/ijgc-2019-001034ISSN 1525-1438Artikkelin verkkoversio.
Jacques E. Rossouw, Garnet L. Anderson, Ross L. Prentice, Andrea Z. LaCroix, Charles Kooperberg, Marcia L. Stefanick, Rebecca D. Jackson, Shirley A. A. Beresford, Barbara V. Howard, Karen C. Johnson, Jane Morley Kotchen, Judith Ockene, Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 17.7.2002, 288. vsk, nro 3, s. 321–333. PubMed:12117397doi:10.1001/jama.288.3.321ISSN 0098-7484Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Matthew M. Symer, Natalie Z. Wong, Jonathan S. Abelson, Jeffrey W. Milsom, Heather L. Yeo: Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clinical Colorectal Cancer, 2018-06, 17. vsk, nro 2, s. e281–e288. PubMed:29398422doi:10.1016/j.clcc.2018.01.003ISSN 1938-0674Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde, Lars Køber, Jens-Erik Beck Jensen: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Victor W. Henderson, Rogerio A. Lobo: Hormone therapy and the risk of stroke: perspectives ten years after the Women’s Health Initiative trials. Climacteric : the journal of the International Menopause Society, 2012-6, 15. vsk, nro 3, s. 229–234. PubMed:22612608doi:10.3109/13697137.2012.656254ISSN 1369-7137Artikkelin verkkoversio.
Laura M. Chambers, Alyssa Herrmann, Chad M. Michener, Cecile A. Ferrando, Stephanie Ricci: Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 2020-04, 30. vsk, nro 4, s. 515–524. PubMed:32075898doi:10.1136/ijgc-2019-001034ISSN 1525-1438Artikkelin verkkoversio.
Jacques E. Rossouw, Garnet L. Anderson, Ross L. Prentice, Andrea Z. LaCroix, Charles Kooperberg, Marcia L. Stefanick, Rebecca D. Jackson, Shirley A. A. Beresford, Barbara V. Howard, Karen C. Johnson, Jane Morley Kotchen, Judith Ockene, Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 17.7.2002, 288. vsk, nro 3, s. 321–333. PubMed:12117397doi:10.1001/jama.288.3.321ISSN 0098-7484Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Matthew M. Symer, Natalie Z. Wong, Jonathan S. Abelson, Jeffrey W. Milsom, Heather L. Yeo: Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clinical Colorectal Cancer, 2018-06, 17. vsk, nro 2, s. e281–e288. PubMed:29398422doi:10.1016/j.clcc.2018.01.003ISSN 1938-0674Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde, Lars Køber, Jens-Erik Beck Jensen: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Victor W. Henderson, Rogerio A. Lobo: Hormone therapy and the risk of stroke: perspectives ten years after the Women’s Health Initiative trials. Climacteric : the journal of the International Menopause Society, 2012-6, 15. vsk, nro 3, s. 229–234. PubMed:22612608doi:10.3109/13697137.2012.656254ISSN 1369-7137Artikkelin verkkoversio.
Victor W. Henderson, Rogerio A. Lobo: Hormone therapy and the risk of stroke: perspectives ten years after the Women’s Health Initiative trials. Climacteric : the journal of the International Menopause Society, 2012-6, 15. vsk, nro 3, s. 229–234. PubMed:22612608doi:10.3109/13697137.2012.656254ISSN 1369-7137Artikkelin verkkoversio.
Laura M. Chambers, Alyssa Herrmann, Chad M. Michener, Cecile A. Ferrando, Stephanie Ricci: Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 2020-04, 30. vsk, nro 4, s. 515–524. PubMed:32075898doi:10.1136/ijgc-2019-001034ISSN 1525-1438Artikkelin verkkoversio.
Jacques E. Rossouw, Garnet L. Anderson, Ross L. Prentice, Andrea Z. LaCroix, Charles Kooperberg, Marcia L. Stefanick, Rebecca D. Jackson, Shirley A. A. Beresford, Barbara V. Howard, Karen C. Johnson, Jane Morley Kotchen, Judith Ockene, Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 17.7.2002, 288. vsk, nro 3, s. 321–333. PubMed:12117397doi:10.1001/jama.288.3.321ISSN 0098-7484Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)
Matthew M. Symer, Natalie Z. Wong, Jonathan S. Abelson, Jeffrey W. Milsom, Heather L. Yeo: Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clinical Colorectal Cancer, 2018-06, 17. vsk, nro 2, s. e281–e288. PubMed:29398422doi:10.1016/j.clcc.2018.01.003ISSN 1938-0674Artikkelin verkkoversio.
Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, Leif Mosekilde, Lars Køber, Jens-Erik Beck Jensen: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ, 9.10.2012, 345. vsk, s. e6409. PubMed:23048011doi:10.1136/bmj.e6409ISSN 1756-1833Artikkelin verkkoversio. (englanti)